PetMed Express, Inc. (NASDAQ:PETS) saw unusually-high trading volume on Monday after the company announced better than expected quarterly earnings. Approximately 4,392,189 shares traded hands during mid-day trading, an increase of 706% from the previous session’s volume of 544,771 shares.The stock last traded at $47.95 and had previously closed at $40.54.
The company reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.07. The company had revenue of $79.66 million during the quarter, compared to analysts’ expectations of $77.32 million. PetMed Express had a return on equity of 28.67% and a net margin of 10.34%. PetMed Express’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.32 EPS.
The firm also recently declared a quarterly dividend, which was paid on Friday, August 18th. Investors of record on Monday, August 7th were issued a $0.20 dividend. The ex-dividend date was Thursday, August 3rd. This represents a $0.80 dividend on an annualized basis and a yield of 1.81%. PetMed Express’s payout ratio is 61.54%.
In other PetMed Express news, Director Robert C. Schweitzer sold 2,500 shares of the stock in a transaction that occurred on Tuesday, August 1st. The stock was sold at an average price of $49.18, for a total transaction of $122,950.00. Following the completion of the transaction, the director now owns 88,834 shares of the company’s stock, valued at $4,368,856.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Ronald J. Korn sold 5,000 shares of the stock in a transaction that occurred on Friday, July 28th. The shares were sold at an average price of $48.18, for a total value of $240,900.00. Following the transaction, the director now directly owns 67,333 shares of the company’s stock, valued at approximately $3,244,103.94. The disclosure for this sale can be found here. Insiders have sold 19,333 shares of company stock valued at $949,730 in the last three months. Insiders own 4.00% of the company’s stock.
Institutional investors have recently made changes to their positions in the stock. Dynamic Technology Lab Private Ltd purchased a new position in shares of PetMed Express during the second quarter worth approximately $412,000. WINTON GROUP Ltd purchased a new position in shares of PetMed Express during the second quarter worth approximately $1,079,000. Koch Industries Inc. purchased a new position in shares of PetMed Express during the second quarter worth approximately $212,000. Bank of Nova Scotia bought a new stake in PetMed Express during the second quarter valued at approximately $781,000. Finally, Arrowstreet Capital Limited Partnership bought a new stake in PetMed Express during the second quarter valued at approximately $1,091,000. 79.12% of the stock is owned by institutional investors and hedge funds.
The company’s 50 day moving average is $44.40 and its 200-day moving average is $31.08. The company has a market capitalization of $898.73 million, a PE ratio of 34.07 and a beta of 0.99.
About PetMed Express
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
What are top analysts saying about PetMed Express Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for PetMed Express Inc. and related companies.